Seven hospitals to acquire linear accelerators and sophisticated software for radiation therapy ISTANBUL, January 16 – Elekta (EKTA-B.ST) has received an order from the Republic of Turkey’s Ministry of Health (Directorate General of Health for Border and Coastal Areas (http://www.hssgm.gov.tr/EN/Default.aspx)) for nine Elekta Synergy® (http://www.elekta.com/synergy) linear accelerators (linacs), all including Agility™ (http://www.elekta.com/agility) multileaf collimators for high-resolution beam shaping, as well as Monaco® (http://www.elekta.com/monaco) 5.0 treatment planning system and MOSAIQ® (http://www.elekta.com/mosaiq) oncology information system. Elekta Synergy allows physicians to better visualize tumors while Agility enables precise shaping of the radiation beam around the tumor. Using volumetric modulated arc therapy (VMAT) technology facilitates rapid treatment time, benefitting both the hospitals and patients. According to the World Health Organization, almost 258 per 100,000 people in Turkey are diagnosed with cancer each year[1] (http://connect.ne.cision.com#_ftn1). Cancer is the second leading cause of death in Turkey and the most common cancers for men and women are lung and breast, respectively. Elekta Synergy has been clinically proven to be effective in managing both types of cancer, as well as several other indications.[2] (http://connect.ne.cision.com#_ftn2) [3] (http://connect.ne.cision.com#_ftn3) Ian Alexander, Executive Vice President of Elekta's Region Europe, Africa, Latin America and Middle East, says: “We are delighted to provide the treatment solutions that will allow the Turkish Ministry of Health to offer state-of-the -art cancer care. We’re especially pleased that many of the hospitals are new customers to Elekta. “This is the first major deal procured by our new entity, Elekta Turkey, which was developed through the recent acquisition of Mesi Medikal (http://bit.ly/1ynxQ2O). We look forward to increased collaboration between our unit and the country’s health care sector.” Elekta was awarded the contract based on a public tender where price and performance were the key criteria. The total value of the deal is almost EUR 16 million (approximately USD 18.5 million) and has been booked during Elekta’s third quarter 2014/15. ---------------------------------------------------------------------- [1] (http://connect.ne.cision.com#_ftnref1) The International Agency for Research on Cancer (IARC), GLOBOCAN project (http://globocan.iarc.fr/Pages/fact_sheets_population.aspx) [2] (http://connect.ne.cision.com#_ftnref2) Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates Published online Nov 11, 2014. doi: 10.1186/s13014-014-0243 -1 (http://dx.doi.org/10.1186%2Fs13014-014-0243-1) [3] (http://connect.ne.cision.com#_ftnref3) Single-Arc Volumetric Modulated Arc Therapy Planning for Left Breast Cancer and Regional Nodes (http://paperity.org/p/34538608/single-arc-volumetric-modulated-arc -therapy-planning-for-left-breast-cancer-and-regional) Journal of Radiation Research, Jan 2012 # # # For further information, please contact: Tobias Bülow, Director Financial Communication, Elekta AB Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com Time zone: CET: Central European Time Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com Time zone: CET: Central European Time The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on January 16, 2015. About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
Turkish Republic, Ministry of Health ‘Türkiye Hudut ve
Top 10 Most Recent News Articles
APP Group's New Conservation Efforts in Sumatra
Taking a Bold Step Towards Conservation APP Group, in collaboration with Proforest, WWF-Indonesia, and KKI WARSI, is setting its sights on a more sustainable future with the PROTECT30 initiative. This isn't just another dime-a-dozen CSR project—it’s a concerted effort aimed at conserving Sumatra's precious Bukit Tigapuluh landscape. These folks are playing the long...
Continue Reading
Mobile Health Program Drives Down Hospital Visits
The wheels are literally in motion in South Broward, with Memorial Healthcare System's Mobile Health Program taking healthcare to the doorstep of thousands. This killer initiative slashed hospital admissions by a nifty 62% among its users in 2025, and they ain't slowing down in 2026. Talk about bringing the doctor to the streets and changing lives! Healthcare On Wheels:...
Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing
The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...
Continue Reading
Frederick Foundation Welcomes New Leaders for Growth
Stirring the Philanthropic Pot in Frederick Moving pieces around the community chessboard once again, the Community Foundation of Frederick County brings in fresh minds—and the stakes have never been higher for these charitable endeavors. They've just put RaeAnn E. Butler at the helm, an established presence who’s now the primary captain steering this ship. Come...
Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms
FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...
Continue Reading
IBM's Quantum Leap in Chicago Puts Illinois on Map
Chicago Steps into the Quantum Race In a world where cutting-edge tech isn't just desired, it's demanded, Chicago's just put itself on the quantum map with IBM's latest move. The unveiling of IBM Quantum System Two at the University of Chicago marks a milestone not just for the city, but for Illinois at large. This isn't some pie-in-the-sky tech dream—it's a tangible...
Continue Reading
Accrete Teams with TenderAlpha: Supply Chain Insights Ahead
Diving Deep into Supply Chain Disturbances Accrete's making waves in the supply chain game with a fresh move that's got the sector talking. Partnering with TenderAlpha, they're pulling strings to provide federal agencies with deeper supply chain insights. You see, Accrete, the brainy bunch driving Knowledge Engines, is sharpening its focus on those unseen tangles in the...
Continue Reading
MNTN Revenue Miss Sparks Shareholder Investigation
When Revenue Goes South, Shares Follow Nothing like a Friday morning stock bloodbath to shake things up. MNTN, Inc. (NYSE:MNTN) had traders tossing back extra caffeine shots on November 5, 2026, when the company reported third-quarter revenues of $80.3 million. Let's just say that number didn't quite sit well with the folks who'd been banking on an $87.7 million...
Continue Reading
Crunch Fitness Invests $5M in Jurupa Valley Expansion
New Era for Crunch Fitness in Jurupa Valley When you've been around the block as much as some of us have, you learn to spot the makings of a solid investment. Fitness Ventures isn't just tossing another gym into the sea of treadmills and barbells; they're making waves with their new $5 million Crunch 3.0 club in Jurupa Valley. This isn't some half-baked, pop-up fitness...
Continue ReadingTop 5 Most Recently Viewed Articles
Riot Platforms Inc: A Strong Buy Rating from Analysts
Riot Platforms Gains Analyst Attention Top analysts have recently made significant changes to their outlooks on various stocks, including Riot Platforms Inc (NASDAQ: RIOT). These rating updates come as optimistic trends in the market emerge, influencing analyst perspectives. Positive Rating Initiation for Riot Platforms Arete Research has initiated coverage on Riot...
Continue Reading
Akeso Showcases Groundbreaking IL-1RAP Antibody Research
Akeso Showcases Groundbreaking IL-1RAP Antibody Research Akeso, Inc. (HKEX: 9926.HK) has unveiled promising data from preclinical studies of a new monoclonal antibody known as AK135. This innovative treatment specifically targets the IL-1 receptor accessory protein (IL-1RAP) and effectively blocks multiple pro-inflammatory pathways. The recent findings were presented at a...
Continue Reading
Investing in Wingstop: Growth Prospects Amid Challenges
Why You Should Pay Attention to Wingstop Stock Right Now Wingstop Inc. (NASDAQ: WING) is showing impressive growth driven by its strategic expansion efforts, strong franchise models, and advancements in technology. Even though the company is navigating some challenges in the larger economic environment, its focus on increasing shareholder value makes it an interesting...
Continue Reading
Health Enterprise Partners Celebrates David Rauber's Advancement
Health Enterprise Partners Promotes David Rauber Health Enterprise Partners (HEP), a renowned healthcare private equity firm, is thrilled to announce the promotion of David Rauber to Vice President, recognizing his significant contributions since he joined the firm in 2021. Celebrating David's Achievements David's journey within HEP has been marked by excellence and...
Continue Reading
I&M Partners with Big Tech for Enhanced Power Solutions
Strengthening the Power Grid through Collaboration Indiana Michigan Power (I&M), a subsidiary of American Electric Power (NASDAQ: AEP), is making significant strides in advancing grid reliability and supporting local economies. By joining forces with major tech companies such as Amazon Web Services (AWS), Microsoft, and Google, I&M aims to enhance its operational capacity...
Continue Reading